COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, July 16, 2021 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
83 new cases, bringing the total number of people infected to 376,192;
364,328 people have recovered;
3 new deaths, for a total of 11,235 deaths:
0 deaths, in the last 24 hours;
3 deaths before July 14;
84 hospitalizations, for an increase of 3;
25 people in intensive care, for an increase of 2;
16,406 samples conducted on July 14.
Vaccination
101,415 doses administered are added, that is 99,852 doses in the last 24 hours and 1,563 doses before July 15, for a total of 9,853,761 doses administered in Québec. Outside Québec, a total of 30,484 doses were administered, for a cumulative total of 9,884,245 doses received by Quebecers.
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect in your region.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...